Policy & Regulation: Page 35
-
PharmaVoice Team/PharmaVoice
Cover
On the Cover Featured on the Cover Competitive Intelligence: Driving Better Decision Making Channeling a New Direction with Neil Levine Global Trials: Tapping New Opportunities September 2004 Volume 4 Number 9 www.pharmavo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Medication Safety, Eight Focus Areas
Medication Safety 8 Focus Areas Long before the topic became part of a broader, national dialogue, the responsibility to improve patient safety was top of mind with nearly every professional within the vast chain of healthcare. But significant improvements are often difficult to achieve and elusi...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendlineâž”
Stock via Getty Images
TrendlineRare diseases
As drug developers find promise in the rare diseases, deals and treatments are on the rise
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies inChord Launches Stonefly Communications Group New agency will use customer-centric business model. inChord Communications Inc. has launched a new full-service advertising agency: Stonefly Communications Group, which will focus o...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies PhRMA Adopts Clinical-Trial Principles Voluntary principles describe the relationship of PhRMA companies with others involved in clinical research and establish the rules to protect the safety of research participants. The Pharma...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Christopher Clement Savient Pharmaceuticals Names CEO Savient Pharmaceuticals has named Christopher Clement CEO, in addition to his role as president. Savient, East Brunswick, N.J., is engaged in developing, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Improving Advocacy Relations
Improving Advocacy relations By Elisabeth Pena By forming relationships with advocacy organizations, pharmaceutical companies can better serve their target patient populations, which in turn will give them allies in the court of public opinion. P harmaceutical companies are in the middle of a pub...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Life-Cycle Management: The Ultimate Client-Agency Relationship
Life-cycle Management The Ultimate Client-Agency Relationship By Elisabeth Pena With $80 billion of products facing patent expiration by 2008, fewer drugs in the pipeline, greater generic competition, and decreasing revenue and growth rates, the pharmaceutical industry is facing some of its bigge...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: A Look at Americans’ Health and Wellness Sidebar: How Americans View Stem-Cell Research Support for Stem-Cell Research Increases Sidebar: The Tufts CSDD Survey Findings Cost Considerations Drive Formulary Approv...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On the Cover Era of Efficiency? Provider Selection and the RFP Process Service providers to the pharmaceutical industry, from agencies to CROs to IT companies to market-research firms, are facing a paradigm shift as sponsors continue to move the provider selection process into the hands of procu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Featured on the Cover A Shift in the RFP Process Driving Performance with Edward Ludwig Biosimulation Advancing Drug Discovery Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Learning How Doctors Learn: Research to Realism in CME
View on CME In an exclusive to PharmaVOICE, Anne Goodrich, Director of Research at The Pri-Med Institute, and Joe Panepinto, Ph.D., VP at Pri-Med Online, discuss four key themes for the success of any CME enterprise aimed at practicing clinicians. The continuous challenge for providers of profess...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than 150 industry events a ye...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive Appointments and Promotions in the Healthcare Industry Featured Talent: Pharma POOL Michael D. Kishbauch, Achillion Pharmaceuticals Kee Moore, STADA Pharmaceuticals Luis VĂ©lez, STADA Pharmaceuticals Dr. Michael Shalmi, Novo Nordisk Biotech POOL Katrine Bosley, Compound Therapeutics ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry A Look at Americans’ Health and Wellness About 57 million Americans have been diagnosed with hypertension, and the number of Americans with hypertension has increased 46% since 1998, according to the latest Nationa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
-
PharmaVoice Team/PharmaVoice
Cover
Cover November 2004 PharmaVOICE The forum for the industry executive A Shift in the RFP process driving performance with Edward Ludwig biosimulation Advancing Drug Discovery Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool Executive Appointments and Promotions Pharma POOL Michael D. Kishbauch Achillion Appoints CEO Achillion Pharmaceuticals has named Michael D. Kishbauch CEO. Mr. Kishbauch replaces Marios Fotiadis, who was acting as interim CEO. Before joining Achillion, New Haven, Conn., Mr. Kishbauch ...
By PharmaVoice Team • Jan. 2, 2008
Previous
To find more content, use the "Topics" in the menu above.
